New eye drops aim to improve corneal transplant outcomes in fuchs dystrophy
NCT ID NCT07024693
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental eye drop called DT-168 in people with Fuchs endothelial corneal dystrophy who are already scheduled for a corneal transplant. The goal is to see if the drops are safe and affect disease-related markers. About 28 adults aged 30 and older with a specific genetic change will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUCHS ENDOTHELIAL CORNEAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
DTX-168-201 Study Site
RECRUITINGIndianapolis, Indiana, 46260, United States
-
DTX-168-201 Study Site
RECRUITINGGrand Rapids, Michigan, 49546, United States